Yangzhou Liberty Pharmaceutical Co., Ltd, established in 2004, is a manufacturer of digestive system drugs and prophylactic biological products with a strong regulatory compliance track record, having passed EU GMP inspection by Germany's B.G.V. Hamburg in 2015, US FDA inspection in 2017, EDQM and ANSM inspection in 2019, and China GMP inspection in 2020. Offering own-brand production to customers across North and South America, Europe, Asia, the Middle East, and Africa, the company competes on international approvals, experienced R&D staff, production capacity, and quality service.
No comments available.
Leave your rating & comment